Clinical Trial: A Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of TIX100 in Healthy Subjects

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06800729) titled 'A Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of TIX100 in Healthy Subjects' on Jan. 23.

Brief Summary: A Single Center, Single Dose, Randomized, Placebo-controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects

Study Start Date: Jan., 2025

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: TIX100, an orally available inhibitor of thioredoxin-interacting protein

TIX100, an orally available inhibitor of thioredoxin-interacting protein

DRUG: Placebo

placebo

Recruitment Status: RECRUITING

Sponsor: TIXiMED, Inc.

Disclaimer: ...